SchizophreniaArchives
Preparation and evaluation of Prochlorperazine Maleate loaded nanostructured lipid carrier for the treatment of schizophrenia
Schizophrenia 1 min.
Schizophrenia management using conventional oral antipsychotic formulations is constrained by poor bioavailability, extensive first-pass metabolism, and dose-related systemic adverse effects. Intranasal drug delivery using nanocarrier systems has emerged as a promising strategy for direct brain targeting...
Analyzing the direct medical cost of schizophrenia in Hospital Pulau Pinang, Malaysia
Schizophrenia 1 min.
Schizophrenia (SCZ) is a major public health concern that places a significant economic burden on healthcare systems. This study assessed the direct medical costs of SCZ and examined cost drivers at Hospital Pulau Pinang (HPP), Malaysia. To estimate and compare direct medical costs for SCZ patients across...
The Cancer Screening Disparity among Women With Schizophrenia by Co-occurring Chronic Physical Illness Status: A Nationwide Cohort Study in Taiwan
Schizophrenia 1 min.
To investigate the association between co-occurring chronic physical illnesses (CPIs) and breast and cervical cancer screening rates among women with schizophrenia in Taiwan. Study Methods: This retrospective cohort study analyzed Taiwan National Health Insurance claims data from 2017 to 2019. The sample...
Neurophysiological Resting-State Markers of Catatonia in Schizophrenia and Mood Disorders
Schizophrenia 1 min.
Identifying reliable diagnostic biomarkers in catatonia remains a key challenge to improve early intervention and reduce morbidity and mortality. Since its pathophysiology may involve cortical dysconnectivity, electroencephalography (EEG) could provide accessible disease-associated measures, such as...
